FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen